Entyce for Dogs
How Entyce (capromorelin) stimulates appetite in dogs — the ghrelin receptor science, dosing, side effects, and when appetite stimulants are the right
Quick Answer: What Is Entyce and How Does It Work in Dogs?
Entyce® (capromorelin oral solution) is an FDA-approved prescription appetite stimulant for dogs. It works by mimicking ghrelin — the body's natural "hunger hormone" — binding to ghrelin receptors in the hypothalamus to trigger the sensation of hunger. Unlike older appetite stimulants that relied on sedation or anti-nausea effects, Entyce directly activates the biological hunger pathway. It is prescribed at 3 mg/kg (1.4 mg/lb) once daily and typically produces noticeable appetite improvement within 1 to 4 hours of the first dose. A 30 mL bottle (10 mg/mL concentration) typically costs $65–$95 depending on your pharmacy and dog's weight.
Entyce is a prescription medication. Always consult your veterinarian before starting any appetite stimulant.
The Ghrelin System: Why Entyce Works at a Molecular Level
How Hunger Signaling Works in the Canine Brain
Appetite regulation in dogs — as in all mammals — is governed by a complex interplay between the gut, the bloodstream, and the hypothalamus. At the center of this system is ghrelin, a 28-amino-acid peptide hormone primarily secreted by the oxyntic cells of the stomach lining.
When the stomach is empty, ghrelin levels rise. This hormone crosses the blood-brain barrier and binds to growth hormone secretagogue receptors (GHS-R1a) in the arcuate nucleus of the hypothalamus. These receptors activate two key neuron populations:
- NPY/AgRP neurons (neuropeptide Y / agouti-related peptide) — these stimulate hunger and reduce metabolic rate
- POMC/CART neurons (pro-opiomelanocortin / cocaine-and-amphetamine-regulated transcript) — these suppress appetite and increase energy expenditure
Ghrelin tips this balance toward the orexigenic (appetite-stimulating) side. The result: your dog feels hungry and seeks food.
Capromorelin, the active ingredient in Entyce, is a ghrelin receptor agonist — a synthetic molecule designed to fit into the same GHS-R1a receptor that natural ghrelin occupies. When capromorelin binds to these receptors, it produces the same downstream effect as endogenous ghrelin: the brain interprets the signal as "I'm hungry," even if the stomach isn't actually empty.
This is a fundamentally different mechanism from older veterinary appetite stimulants:
| Medication | Active Ingredient | Mechanism of Action | FDA-Approved for Dogs? |
|---|---|---|---|
| Entyce® | Capromorelin (10 mg/mL) | Ghrelin receptor agonist — directly stimulates hunger center | Yes (2016) |
| Mirtazapine | Mirtazapine | Serotonin 5-HT2C and histamine H1 antagonist — appetite increase is a secondary effect | No (extra-label use) |
| Cyproheptadine | Cyproheptadine HCl | Antihistamine/antiserotonergic — blocks serotonin-mediated satiety signals | No (extra-label use) |
| Cerenia® | Maropitant citrate | NK-1 receptor antagonist — reduces nausea, may indirectly improve appetite | Yes (for vomiting, not appetite) |
What makes Entyce unique is its specificity. It doesn't sedate the dog, alter serotonin levels broadly, or simply reduce nausea. It directly activates the hunger pathway — which is why clinical trials showed appetite improvement in a majority of treated dogs without the drowsiness commonly seen with mirtazapine.
The Evolutionary Basis: Why Dogs Have Such a Robust Ghrelin System
From Feast-or-Famine Wolves to Modern Dogs
The ghrelin hunger system evolved under intense selective pressure in ancestral canids. Wild wolves and early dogs lived in a feast-or-famine feeding ecology — they might consume 10–20% of their body weight in a single successful hunt, then go 5–14 days without food. A highly responsive ghrelin system was essential for survival:
- Rapid hunger signaling ensured that wolves would actively seek food when energy reserves dropped, rather than becoming lethargic and missing hunting opportunities
- Growth hormone release (a secondary effect of ghrelin receptor activation) supported tissue repair and lean mass maintenance during periods of nutritional stress
- Gastric motility stimulation prepared the digestive tract to process large meals efficiently when food became available
Domestication has not eliminated this system. Modern dogs retain the same ghrelin receptor architecture as their wolf ancestors — which is precisely why capromorelin (a synthetic ghrelin mimetic) works so effectively in dogs. The receptor hasn't changed in roughly 15,000–30,000 years of domestication.
Research published in the Journal of Veterinary Internal Medicine has confirmed that dogs with chronic illness often show dysregulated ghrelin signaling — their bodies may produce ghrelin but the signal fails to translate into feeding behavior, possibly due to inflammatory cytokines (particularly TNF-α and IL-1β) that interfere with hypothalamic processing. This is why simply offering more appealing food often fails in sick dogs: the problem isn't pickiness, it's a broken hunger signal.
Clinical Evidence: What the Research Shows About Entyce in Dogs
The pivotal clinical trial for Entyce (then known as capromorelin oral solution) was a multi-site, randomized, double-blind, placebo-controlled field study — the gold standard of veterinary pharmaceutical research.
Key Clinical Trial Findings
- Study design: Dogs with clinical inappetence (reduced appetite for ≥2 days due to underlying illness) were randomized to receive capromorelin 3 mg/kg or placebo once daily for 8 days
- Primary endpoint: Client-reported appetite assessment on a validated scale
- Results: Dogs receiving capromorelin showed statistically significant improvement in appetite scores compared to placebo by Day 1, with continued improvement through Day 8
- Owner observations: Most owners reported their dogs began eating within 1–4 hours of the first dose
- Body weight: Treated dogs showed a trend toward weight stabilization or modest gain over the study period
It's important to understand what Entyce does not do. It does not treat the underlying cause of inappetence — whether that's kidney disease, cancer, gastrointestinal illness, dental pain, or medication side effects. It is a supportive therapy designed to maintain nutritional intake while the primary condition is being managed. Your veterinarian will always want to identify and address the root cause of your dog's appetite loss.
Practical Dosing and Administration Guide
Entyce comes as a flavored oral solution (10 mg/mL) administered with a calibrated dosing syringe. Here's what the dosing looks like across common dog weight ranges:
| Dog Weight (lb) | Dog Weight (kg) | Dose (mg) | Volume per Dose (mL) | 30 mL Bottle Lasts |
|---|---|---|---|---|
| 10 lb | 4.5 kg | 13.5 mg | 1.35 mL | ~22 days |
| 25 lb | 11.3 kg | 34 mg | 3.4 mL | ~9 days |
| 50 lb | 22.7 kg | 68 mg | 6.8 mL | ~4 days |
| 75 lb | 34 kg | 102 mg | 10.2 mL | ~3 days |
| 100 lb | 45.4 kg | 136 mg | 13.6 mL | ~2 days |
Cost reality for larger dogs: At current retail pricing of $65–$95 per 30 mL bottle, a 75 lb dog could cost $600–$900+ per month on Entyce. For large-breed dogs requiring long-term appetite support, discuss cost-effective alternatives or compounded formulations with your veterinarian.
Administration Tips
- Administer directly into the mouth using the provided syringe — aim for the cheek pouch, not the back of the throat
- Can be given with or without food, but consistency matters — pick a routine and stick with it
- Do not mix into food, as incomplete consumption means incomplete dosing
- Store at room temperature (68–77°F / 20–25°C); do not refrigerate or freeze
- Shake the bottle gently before each use
Side Effects, Contraindications, and Safety Profile
Entyce is generally well-tolerated, but like all medications, it carries potential side effects. Understanding these helps you distinguish normal drug effects from concerning reactions.
| Side Effect | Frequency | What to Expect | Action Required |
|---|---|---|---|
| Vomiting | Common (~15–20% of dogs) | Usually mild, occurs within first few days of treatment | Monitor; usually resolves without dose change |
| Diarrhea | Common (~10–15%) | Soft stools, typically transient | Monitor hydration; report if >3 days |
| Hypersalivation (drooling) | Occasional (~8–12%) | Often related to the taste of the solution | Normal; offer water after dosing |
| Head shaking | Occasional (~5–8%) | Reaction to oral administration | Usually resolves with technique adjustment |
| Increased thirst/polydipsia | Less common | Ghrelin may influence fluid regulation | Report to vet if excessive |
| Elevated liver enzymes | Rare | Noted in some long-term use cases | Vet may recommend periodic bloodwork |
When to Contact Your Veterinarian Immediately
- Persistent vomiting (more than 2 episodes in 24 hours)
- Signs of an allergic reaction: facial swelling, hives, difficulty breathing
- Severe lethargy or collapse
- Your dog refuses all food for more than 48 hours despite Entyce treatment — this suggests the underlying condition is worsening
- Blood in vomit or stool
Consult your veterinarian before starting Entyce if your dog has pre-existing liver disease, is pregnant or lactating, or is taking other medications that may interact with ghrelin receptor pathways.
Contraindications: Entyce has not been evaluated in dogs less than 6 months of age, in breeding dogs, or in pregnant/lactating dogs. Use with caution in dogs with hepatic impairment — capromorelin is metabolized primarily by the liver via CYP3A enzymes.
Common Misconceptions About Entyce and Canine Appetite
| Misconception | What the Science Says |
|---|---|
| "Entyce is just a vitamin supplement." | Entyce is a prescription pharmaceutical — capromorelin is a synthetic ghrelin receptor agonist with a specific pharmacological mechanism. It is not a supplement, vitamin, or nutraceutical. |
| "My dog is just being picky — Entyce will fix that." | Entyce is indicated for clinical inappetence associated with underlying disease, not behavioral food selectivity in healthy dogs. A picky eater who is otherwise healthy does not need pharmacological intervention. |
| "Entyce will make my dog gain weight." | Entyce restores appetite toward normal — it does not create hyperphagia (excessive eating). Weight changes depend on what and how much the dog eats once appetite returns. It is not a weight-gain drug. |
| "It's the same as human appetite stimulants." | Entyce (capromorelin) is species-specific in its approval. While ghrelin biology is conserved across mammals, capromorelin was developed and tested specifically for canine use. A feline formulation (Mirataz-like application) was developed separately. |
| "Once my dog starts eating, I can stop Entyce immediately." | Discontinuation timing depends on the underlying condition. Some dogs need short-term support (days to weeks); dogs with chronic conditions like CKD or cancer may need ongoing therapy. Always follow your vet's guidance on duration. |
Breed Variations and Individual Differences in Ghrelin Response
While Entyce works across all breeds at the standard 3 mg/kg dose, individual response varies — and some of this variation has breed-linked components:
- Sighthounds (Greyhounds, Whippets, Italian Greyhounds): These breeds have notably different body composition (very low body fat, high lean mass) and altered drug metabolism profiles. While capromorelin dosing doesn't change, their baseline ghrelin dynamics may differ slightly due to lower adipose tissue (which produces leptin, a ghrelin antagonist). Monitor closely for efficacy.
- Brachycephalic breeds (Bulldogs, Pugs, Boston Terriers): These dogs often have chronic low-grade respiratory stress that can independently suppress appetite. Entyce may be effective, but addressing BOAS (brachycephalic obstructive airway syndrome) concurrently is critical.
- Working and sporting breeds (Labrador Retrievers, German Shepherds): Labradors carry a well-documented POMC gene mutation that affects satiety signaling — making them prone to obesity. In these dogs, Entyce may be too effective at stimulating appetite if the underlying cause of inappetence resolves. Careful monitoring of caloric intake during and after treatment is essential.
- Toy breeds (Chihuahuas, Yorkshire Terriers): Very small dogs face higher risk of hypoglycemia during periods of inappetence. Entyce can be particularly valuable here, but the small dosing volumes (often <1 mL) require precise measurement with the provided syringe.
When Inappetence Signals Something Deeper
Understanding the cause of reduced appetite is as important as treating the symptom. Inappetence (the clinical term for reduced appetite, distinct from anorexia which means complete food refusal) can signal:
- Acute conditions: Gastrointestinal obstruction, pancreatitis, infectious disease (parvovirus, leptospirosis), toxin ingestion, dental abscess
- Chronic conditions: Chronic kidney disease (CKD) — one of the most common causes of persistent inappetence in senior dogs — liver disease, hypothyroidism, Addison's disease, cancer
- Medication side effects: NSAIDs, chemotherapy agents, certain antibiotics, and digoxin commonly suppress appetite
- Pain: Any significant pain source — osteoarthritis, spinal disease, abdominal discomfort — can reduce appetite through stress-mediated cortisol elevation, which suppresses ghrelin release
- Psychological/behavioral: Environmental stress, separation anxiety, recent rehoming, or changes in household dynamics can cause stress-induced inappetence
The 48-Hour Rule
A healthy adult dog can safely fast for 24–48 hours without nutritional harm. However, any dog that refuses all food for more than 48 hours needs veterinary evaluation — not just an appetite stimulant. Puppies, toy breeds, and dogs with pre-existing conditions should be seen sooner (within 24 hours). Entyce is a tool to support your dog while the underlying cause is diagnosed and treated — it is not a substitute for diagnostic workup.
Related Canine Science: Cross-Referenced Behaviors and Mechanisms
The ghrelin system doesn't operate in isolation. Understanding these connected systems gives you a more complete picture of your dog's appetite and feeding behavior:
- Leptin signaling: Produced by adipose (fat) tissue, leptin is ghrelin's physiological opposite — it signals satiety. Obese dogs often have elevated leptin but develop leptin resistance, similar to insulin resistance in type 2 diabetes. This is why overweight dogs may seem "always hungry" despite adequate caloric intake.
- Conditioned taste aversion: Dogs that experience nausea after eating a specific food may develop long-term aversion to that food — even after the nausea resolves. This is an evolutionary adaptation (avoiding toxic foods) but can complicate nutritional support in chronically ill dogs. Rotating protein sources and food textures can help.
- Circadian ghrelin rhythms: Ghrelin secretion follows a circadian pattern in dogs, with peaks typically occurring in the morning and early evening. This is why many dogs show stronger appetite at these times — and why timing Entyce administration to coincide with these natural peaks may enhance effectiveness.
- Scavenging and coprophagia: The evolutionary drive to eat when food is available (ghrelin-mediated) helps explain why dogs scavenge and sometimes eat feces — behaviors that seem repulsive to humans but made survival sense in ancestral environments where caloric opportunities were unpredictable.
Frequently Asked Questions
Why does my dog need an appetite stimulant instead of just better food?
When a dog has clinical inappetence due to illness, the problem isn't the food — it's a disrupted hunger signaling pathway. Inflammatory cytokines, metabolic imbalances, and nausea can all override the normal ghrelin-driven hunger response. No amount of rotisserie chicken will fix a broken signaling pathway. Entyce restores the signal so the dog wants to eat, regardless of what's offered.
Can Entyce be used long-term in dogs with chronic kidney disease?
Yes — many veterinary internists use capromorelin as part of long-term CKD management to maintain caloric intake. However, periodic monitoring of liver enzymes and overall metabolic status is recommended. Your veterinarian will determine appropriate bloodwork intervals (typically every 3–6 months for stable CKD patients on Entyce).
How is Entyce different from simply feeding my dog by hand or syringe-feeding?
Assisted feeding (hand-feeding, syringe-feeding a recovery diet) provides calories but doesn't address the underlying appetite deficit — and can create food aversion if the dog associates eating with stress. Entyce works to restore voluntary eating behavior, which is nutritionally and psychologically preferable. That said, assisted feeding may be necessary as a bridge while waiting for Entyce to take effect or in cases where the dog is too debilitated to eat voluntarily.
Is Entyce safe for dogs on other medications?
Capromorelin has a relatively low drug-interaction profile, but it is metabolized via the hepatic CYP3A pathway. Medications that inhibit or induce CYP3A (such as ketoconazole, itraconazole, or phenobarbital) could theoretically alter capromorelin blood levels. Always provide your veterinarian with a complete medication list — including supplements and OTC products — before starting Entyce.
What should I do if Entyce doesn't work for my dog?
If there's no meaningful appetite improvement after 3–5 days of consistent dosing, your veterinarian may: (1) reassess the underlying diagnosis, (2) try an alternative appetite stimulant such as mirtazapine, (3) add an anti-nausea medication like maropitant (Cerenia) if nausea is a contributing factor, or (4) consider a feeding tube for nutritional support. Non-response to Entyce doesn't mean nothing can be done — it means the treatment plan needs adjustment.
Is inappetence always a sign of illness?
Not always. Intact females may eat less during estrus (heat cycles). Dogs in hot weather often reduce food intake. Some dogs eat less when stressed by environmental changes. However, any inappetence lasting more than 48 hours warrants veterinary investigation, because early detection of underlying disease significantly improves prognosis.
Sources and References
- FDA — Entyce® (capromorelin oral solution) Approval
- Merck Veterinary Manual — Capromorelin
- AVMA — Canine Nutrition and Appetite Management Guidelines
This article is for educational purposes and does not replace professional veterinary advice. Always consult your veterinarian for diagnosis and treatment decisions regarding your dog's health.
Aaron Whyte
All our authors care for dogs every day — read more of their work on the authors page.
